Yüklüyor......
Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a grea...
Kaydedildi:
| Yayımlandı: | Case Rep Anesthesiol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7303763/ https://ncbi.nlm.nih.gov/pubmed/32566314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8767195 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|